A

Axonics

AXNX

68.420
USD
-0.02
(-0.03%)
مغلق
حجم التداول
7,069
الربح لكل سهم
0
العائد الربحي
0
P/E
-3,520
حجم السوق
3,598,711,565
أصول ذات صلة
ABT
4.220
(3.98%)
110.150 USD
B
BAX
0.190
(0.53%)
36.000 USD
BDX
-4.995
(-2.07%)
236.055 USD
BSX
1.315
(1.78%)
75.170 USD
DHR
3.66
(1.32%)
280.75 USD
ISRG
6.98
(1.57%)
451.27 USD
MDT
0.160
(0.20%)
80.470 USD
SYK
5.59
(1.71%)
332.94 USD
الأخبار المقالات

العنوان: Axonics

القطاع: Healthcare
الصناعة: Medical Devices
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.